The PI3K/AKT signaling pathway also frequently undergoes genetic alterations in ccRCC which include PTEN deletions or mutations, mTOR mutations, and PIK3CA amplifications or mutations. The gene discussed is MTOR; the disease is nonpapillary renal cell carcinoma.